Kelly Jeanne Lafaro MD MPH
Hepatobiliary Surgery, Surgical Oncology (Other than Breast)
Assistant Professor, Division of Surgical Oncology, Johns Hopkins University School of Medicine
Join to View Full Profile
201 North Broadway StreetViragh BLDG 5th FLBaltimore, MD 21287
Phone+1 410-955-8964
Fax+1 410-367-2194
Dr. Lafaro is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Kelly Lafaro is a general surgeon in Baltimore, MD and is affiliated with multiple hospitals in the area, including Johns Hopkins Hospital and Sibley Memorial Hospital. She received her medical degree from Tulane University School of Medicine and has been in practice 7 years. She specializes in hepatobiliary surgery and surgical oncology (other than breast) and is experienced in esophageal cancer, gastric cancer, pancreatic cancer, head and neck oncology and microvascular reconstruction, and surgical oncology (non-breast). She has more than 60 publications and over 500 citings.
Education & Training
City of Hope National Medical CenterFellowship, Complex General Surgical Oncology, 2017 - 2019
New York Presbyterian Hospital (Columbia Campus)Residency, Surgery, 2015 - 2017
Johns Hopkins University School of MedicinePost-Doctoral Fellowship, 2013 - 2015
University of California (Irvine)Residency, Surgery, 2010 - 2013
Tulane University School of MedicineClass of 2010
Certifications & Licensure
FL State Medical License 2021 - Present
DC State Medical License 2019 - 2026
MD State Medical License 2013 - 2026
VA State Medical License 2022 - 2026
NC State Medical License 2020 - 2022
OK State Medical License 2021 - 2021
CA State Medical License 2012 - 2020
American Board of Surgery Surgery- American Board of Surgery Complex General Surgical Oncology
- Join now to see all
Publications & Presentations
PubMed
- Carbohydrate Antigen 19-9 Delta Function for Survival Prediction in Borderline Pancreatic Cancer. A PANC-PALS Consortium International Multicenter Derivation and Valid...Jonathan Garnier, Alessio Marchetti, Brady Campbell, Paul C M Andel, Marie-Sophie Alfano
Annals of Surgery. 2025-04-16 - Prognostic Features in Surgically Resected Well-Differentiated Pancreatic Neuroendocrine Tumors: An Analysis of 904 Patients with 7882 Person-Years of Follow-Up.Ashley L Kiemen, Eric D Young, Amanda L Blackford, Pengfei Wu, Richard A Burkhart
Medrxiv. 2025-04-03 - Neoadjuvant Chemotherapy for Intraductal Papillary Mucinous Neoplasm-derived Pancreatic Cancer.Joseph R Habib, Ingmar F Rompen, Ammar A Javed, Brady A Campbell, Benedict Kinny-Köster
Annals of Surgery. 2025-03-05
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
